Whipplewood Advisors, LLC Genmab A/S Transaction History
Whipplewood Advisors, LLC
- $176 Billion
- Q4 2024
A detailed history of Whipplewood Advisors, LLC transactions in Genmab A/S stock. As of the latest transaction made, Whipplewood Advisors, LLC holds 108 shares of GMAB stock, worth $2,074. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108Holding current value
$2,074% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding GMAB
# of Institutions
228Shares Held
52.2MCall Options Held
10.2KPut Options Held
25.5K-
Alliancebernstein L.P. New York, NY15.1MShares$291 Million0.13% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$97.6 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA4.42MShares$84.9 Million0.02% of portfolio
-
Harding Loevner LP Bridgewater, NJ3.07MShares$58.9 Million0.44% of portfolio
-
Wellington Management Group LLP Boston, MA2.31MShares$44.3 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $12.6B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...